FDA Adverse Event Malfunction Summary report: N

TOTAL (FREE + COMPLEXED) PSA - PROSTATE-SPECIFIC ANTIGEN (TPSA)

MDR report key: 2132641 · Received June 17, 2011

Report

Report Number
1823260-2011-03318
Event Type
Malfunction
Date Received
June 17, 2011
Date of Event
May 23, 2011
Report Date
June 17, 2011
Manufacturer
ROCHE DIAGNOSTICS
Product Code
MTF
PMA / PMN Number
P990056
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
ND, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE OTHER ASSAYS RELATED TO THIS EVENT ARE REPORTED IN MEDWATCH REPORTS PATIENT IDENTIFIERS: (B)(6).

Description of Event or Problem · 1

THE CUSTOMER STATED THEY WERE RECEIVING QUESTIONABLE RESULTS FOR TOTAL PSA (TPSA) ON THEIR MODULAR ANALYTICS E-MODULE (SERIAL NUMBER (B)(4)). THE CUSTOMER PROVIDED DATA FOR 17 SAMPLES OF WHICH THERE WERE TWO WITH DISCREPANT RESULTS REPORTED OUTSIDE THE LABORATORY. A PHYSICIAN QUESTIONED ONE OF THE PSA RESULTS AND THE CUSTOMER REPEAT ALL THE TPSA TESTS PERFORMED THAT DAY. REPEAT TESTING WAS PERFORMED ON THE SAME E- MODULE AND ISSUED AS A CORRECTED REPORT. THE FIRST PATIENT'S INITIAL TPSA RESULT WAS 1.16 NG/ML. THE REPEAT RESULT WAS 7.90 NG/ML. THE SECOND PATIENT'S INITIAL TPSA RESULT WAS 54.91 NG/ML. THE FIRST REPEAT RESULT WAS 100.0 NG/ML ACCOMPANIED BY A DATA FLAG. THE SAMPLE WAS DILUTED AND REPEATED THE SECOND REPEAT RESULT FROM THE ANALYZER WAS 483.3 NG/ML ACCOMPANIED BY A DATA FLAG. THE CUSTOMER WAS NOT AWARE OF ANY ADVERSE AFFECTS TO THE PATIENTS AS A RESULT OF THIS EVENT. THE CUSTOMER REFUSED A SERVICE VISIT. THE CUSTOMER RESOLVED THE ISSUE BY TROUBLESHOOTING THE ANALYZER. THEY PERFORMED LIQUID FLOW CLEANING THREE TIMES AND MEASURING CELL PREPARATION TWENTY TIMES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TOTAL (FREE + COMPLEXED) PSA - PROSTATE-SPECIFIC ANTIGEN (TPSA) TOTAL,PROSTATE SPECIFIC ANTIGEN(NONCOMPLEXED&COMPLEXED) FOR DETECTION OF PROSTAT MTF ROCHE DIAGNOSTICS NA 16144001

Patients

Seq Age Sex Outcome Treatment
1